COMMUNITY SYSTEMS STRENGTHENING RAMEWORK
to deal with major health challenges such as HIV, tuberculosis, malaria and many others. An improvement in health outcomes can be greatly enhanced through mobilization of key affected populations and community networks and an emphasis on strengthening community based and community led systems for:
Download COMMUNITY SYSTEMS STRENGTHENING RAMEWORK
Information
Domain:
Source:
Link to this page:
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Related documents
Mycobacterium bovis (Bovine Tuberculosis) in Humans
www.cdc.gov(M. tuberculosis). Mycobacterium bovis (M. bovis) is another mycobacterium that can cause TB disease in people. M. bovis is most commonly found in cattle and other animals such as bison, elk, and deer. In people, M. bovis causes TB disease that can affect the lungs, lymph nodes, and other parts of the body. However, as with M. tuberculosis,
Latent Tuberculosis Treatment Regimens
www.cdc.govthe National Tuberculosis Controllers Association preferentially recommend short-course, rifamycin-based, 3- or 4-month latent TB infection treatment regimens over 6- or 9-month isoniazid monotherapy. Clinicians should choose the appropriate treatment regimen based on drug susceptibility results of the presumed.
California Pediatric Tuberculosis Risk Assessment and User ...
www.cdph.ca.govCalifornia Pediatric Tuberculosis Risk Assessment • Use this tool to identify asymptomatic children for latent TB infection (LTBI) testing. • Do not repeat testing unless there are new risk factors since the last test. If initial negative screening test occurred prior to 6 months of age, repeat testing should occur at age 6 months or older
cTCA ~k.~.Rt! California School Employee Tuberculosis (TB)
www.cdph.ca.govHistory of Tuberculosis Disease or Infection (Check appropriate box below) Yes •If there is a documented history of positive TB test or TB disease, then a symptom review and chest x-ray (if none performed in the previous 6 months) should be performed at initial hire by a physician, physician assistant, or nurse practitioner. If the x-ray
Tuberculosis Risk Assessment Questionnaire for Workers in ...
www.health.qld.gov.auTuberculosis Risk Assessment Questionnaire for Workers in Hospital and Health Service Facilities Instructions: Please complete the following questions and provide (if available) any supporting documents and additional information as indicated to the Hospital and Health Service (HHS) prior to commencement of employment.
Tuberculosis (TB) Blood Test (IGRA)
www.health.state.mn.usThe tuberculosis (TB) blood test, also called an Interferon Gamma Release Assay or IGRA, is a way to find out if you have TB germs in your body. The TB blood test can be done instead of a TB skin test (Mantoux). There are two kinds of TB blood tests: QuantiFERON®-TB